Organoid models of tumor immunology K Yuki, N Cheng, M Nakano, CJ Kuo Trends in immunology 41 (8), 652-664, 2020 | 266 | 2020 |
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer N Cheng, R Watkins-Schulz, RD Junkins, CN David, BM Johnson, ... JCI insight 3 (22), 2018 | 211 | 2018 |
Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects Y Zhang, N Cheng, R Miron, B Shi, X Cheng Biomaterials 33 (28), 6698-6708, 2012 | 206 | 2012 |
Randomized controlled trial on fluoride varnish application for treatment of white spot lesion after fixed orthodontic treatment M Du, N Cheng, B Tai, H Jiang, J Li, Z Bian Clinical oral investigations 16, 463-468, 2012 | 206 | 2012 |
The inhibitory innate immune sensor NLRP12 maintains a threshold against obesity by regulating gut microbiota homeostasis AD Truax, L Chen, JW Tam, N Cheng, H Guo, AA Koblansky, WC Chou, ... Cell host & microbe 24 (3), 364-378. e6, 2018 | 189 | 2018 |
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination RD Junkins, MD Gallovic, BM Johnson, MA Collier, R Watkins-Schulz, ... Journal of Controlled Release 270, 1-13, 2018 | 135 | 2018 |
Desmoplastic ameloblastoma–A review ZJ Sun, YR Wu, N Cheng, RA Zwahlen, YF Zhao Oral oncology 45 (9), 752-759, 2009 | 108 | 2009 |
Arp2/3 complex is required for macrophage integrin functions but is dispensable for FcR phagocytosis and in vivo motility JD Rotty, HE Brighton, SL Craig, SB Asokan, N Cheng, JP Ting, JE Bear Developmental cell 42 (5), 498-513. e6, 2017 | 106 | 2017 |
Immune receptor inhibition through enforced phosphatase recruitment RA Fernandes, L Su, Y Nishiga, J Ren, AM Bhuiyan, N Cheng, CJ Kuo, ... Nature 586 (7831), 779-784, 2020 | 67 | 2020 |
Porous CaP/silk composite scaffolds to repair femur defects in an osteoporotic model N Cheng, J Dai, X Cheng, S Li, RJ Miron, T Wu, W Chen, Y Zhang, B Shi Journal of Materials Science: Materials in Medicine 24, 1963-1975, 2013 | 53 | 2013 |
The osteogenic potential of mesoporous bioglasses/silk and non-mesoporous bioglasses/silk scaffolds in ovariectomized rats: in vitro and in vivo evaluation N Cheng, Y Wang, Y Zhang, B Shi PloS one 8 (11), e81014, 2013 | 51 | 2013 |
Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung cancer JL Perry, S Tian, N Sengottuvel, EB Harrison, BK Gorentla, CH Kapadia, ... ACS nano 14 (6), 7200-7215, 2020 | 40 | 2020 |
The effect of mesoporous bioglass on osteogenesis and adipogenesis of osteoporotic BMSCs T Wu, N Cheng, C Xu, W Sun, C Yu, B Shi Journal of Biomedical Materials Research Part A 104 (12), 3004-3014, 2016 | 39 | 2016 |
PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment T Wu, L Tan, N Cheng, Q Yan, YF Zhang, CJ Liu, B Shi Materials Science and Engineering: C 62, 888-896, 2016 | 35 | 2016 |
The toll–like Receptor 2/6 agonist, FSL–1 lipopeptide, therapeutically mitigates acute radiation syndrome CJ Kurkjian, H Guo, ND Montgomery, N Cheng, H Yuan, JR Merrill, ... Scientific Reports 7 (1), 17355, 2017 | 34 | 2017 |
Effect of retinoic acid on the function of lipopolysaccharide-stimulated bone marrow stromal cells grown on titanium surfaces Q Yan, Y Li, N Cheng, W Sun, B Shi Inflammation research 64, 63-70, 2015 | 18 | 2015 |
HTNV infection of CD8+ T cells is associated with disease progression in HFRS patients R Liu, R Ma, Z Liu, H Hu, J Shu, P Hu, J Kang, Y Zhang, M Han, X Zhang, ... Communications biology 4 (1), 652, 2021 | 17 | 2021 |
Targeting innate immunity in breast cancer therapy: a narrative review Y Ye, C Xu, F Chen, Q Liu, N Cheng Frontiers in Immunology 12, 771201, 2021 | 16 | 2021 |
STAT3 activation as a predictive biomarker for ruxolitinib response in head and neck cancer Z Qureshy, H Li, Y Zeng, J Rivera, N Cheng, CN Peterson, MO Kim, ... Clinical Cancer Research 28 (21), 4737-4746, 2022 | 11 | 2022 |
Arp2/3 Complex Is Required for Macrophage Integrin Functions But Is Dispensable for FcR Phagocytosis and JD Rotty, HE Brighton, SL Craig, SB Asokan, N Cheng, JP Ting, JE Bear Vivo, 2017 | 8 | 2017 |